The ability to sequence the genome of a tumor has revolutionized cancer treatment over the last 15 years by identifying drivers of cancer at the molecular level. But understanding the genetic diversity of individual cells within a tumor … Read More »
Results are in for the health system’s Prevalence Pilot Program, which reflects COVID-19 testing results among Keck Medical Center of USC health care workers. Conducted over a four-week period in May and June, the program showed infection and … Read More »
On June 22, Chris Allen transitioned from his role as executive administrator for financial planning and decision support at Keck Medicine of USC to that of interim chief financial officer for the organization.
A graduate … Read More »
A rare and spontaneous variant in a gene called SYNGAP1 can lead to a variety of debilitating conditions in infants and children, including intellectual disability, epilepsy and autism spectrum disorders. As of now, there is no cure.